GSA CAPITAL PARTNERS LLP - CASI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$122,000
+212.8%
78,572
+377.9%
0.01%
+133.3%
Q1 2021$39,000
-74.7%
16,442
-68.5%
0.01%
-76.0%
Q4 2020$154,000
+396.8%
52,146
+157.4%
0.02%
+400.0%
Q3 2020$31,00020,2600.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,136,00025.80%
Consonance Capital Management LP 10,540,715$25,298,0002.70%
Wellington Shields & Co., LLC 1,832,769$4,399,0001.58%
Tri Locum Partners LP 1,500,000$3,600,0000.89%
Wellington Shields Capital Management, LLC 2,231,765$5,356,0000.51%
Ghost Tree Capital, LLC 650,000$1,560,0000.37%
1492 Capital Management LLC 159,486$382,0000.11%
Ikarian Capital, LLC 1,268,154$3,044,0000.10%
Sio Capital Management, LLC 203,432$488,0000.10%
Aristides Capital LLC 63,250$152,0000.06%
View complete list of CASI PHARMACEUTICALS INC shareholders